Study Identifies Rare Genetic Variants in Early Psychosis Intervention Patients

A small subset of patients supported by an early psychosis intervention program harbor clinically relevant rare genetic variants, according to an observational study conducted in Canada. Medical researchers screened the clinical records of 899 individuals receiving care through a specialized intervention service to evaluate how frequently genetic conditions are documented in routine practice. The retrospective chart review revealed that thirteen patients possessed at least one rare genetic variant of possible or likely clinical significance.

The investigation was designed to explore an area of clinical psychiatry where systematic real-world data have remained relatively limited. Although numerous genetic disorders associated with the development of psychosis have been well characterized in biomedical literature, little has been known about how common such diagnoses actually are among patients receiving ongoing care through Early Psychosis Intervention Programs. In addition to assessing prevalence, the researchers sought to examine the practical clinical context surrounding these cases, specifically focusing on the circumstances under which a genetic cause was initially suspected, the diagnostic pathways involved, and any resultant implications for patient care.

Conducted in Calgary, Alberta, the observational and retrospective study relied on the systematic screening of charts from 899 patients enrolled in the regional early psychosis program. By reviewing these comprehensive medical records, the authors aimed to map the spectrum of rare genetic variations present across the enrolled patient cohort. An additional patient was also identified who harbored a rare genetic variant that clinicians determined to be non-contributory to the illness.

The researchers carefully distinguished between variants that directly explained psychotic illness and those whose clinical significance remained uncertain. Among the thirteen individuals identified with clinically meaningful variants, clinicians considered five patients to harbor variants that were pathogenic and likely contributed directly to the development of their psychotic illness. In contrast, an association between the detected variant and psychotic symptoms was considered plausible but speculative in eight cases.

The study also analyzed the diagnostic process, paying close attention to how genetic etiologies were first identified during psychiatric treatment. Owing to a variety of suggestive phenotypic features observed during clinical care, treating psychiatry professionals were the first to suspect an underlying genetic etiology in seven cases. Following this initial psychiatric recognition, the formal identification of a genetic variant led to documented clinical implications in five of those seven individuals.

The authors concluded that these findings underscore the need for psychiatrists working in early psychosis settings to actively consider the possibility of underlying genetic conditions among their patients.

Subject of Research: Rare genetic variation and clinical implications in early psychosis intervention

Article Title: Rare Genetic Variation among Individuals Enrolled in an Early Psychosis Intervention Program

Article References: Colijn, M. A. (2026). Rare Genetic Variation among Individuals Enrolled in an Early Psychosis Intervention Program. Community Mental Health Journal. https://doi.org/10.1007/s10597-026-01750-2

Image Credits: AI Generated

DOI: 10.1007/s10597-026-01750-2

Keywords: early psychosis, genetic variants, psychiatry, clinical genetics, early psychosis intervention, retrospective study, pathogenic variants, Rare, Genetic, Variation, Individuals, Enrolled